Skip to main content

Table 1 Demographic details of the COPD and control group

From: Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes

Subjects

Controls

COPD

No. of subjects

10

10

Age (years)

49 (41–57)

58 (42–64)*

FEV1, % pred

108.4 (91–110)

60.1 (44–96)*

FEV1/% FVC

96 (84–108)

58 (43–73)*

Male/Female

8/6

6/4

  1. Data showing median (range)
  2. Abbreviations: FEV1 forced expiratory volume in 1 s, FVC forced vital capacity; *p < 0.05 compared to controls